Diabetes en pacientes que reciben trasplantes de órganos

Abstract

New-onset diabetes after transplantation is a common complication of solid-organ transplantation. The associations between age, gender, body weight, transplant type, diagnosis, family history of diabetes, triglycerides, cholesterol, glucose, hepatitis C virus infection, and immunosuppressive therapies and NODT should be evaluated in each population. The aim of this study was to evaluate the risk factors for post transplantation diabetes. Methods: I retrospectively studied 53 patients who had received a transplant. The follow-up period was 3 months to 3 years. Results: 11.3% patients developed diabetes. The risk factor significantly associated with the development of diabetes were glucose pretransplant OR 1.79 and cyclosporin A 0.84. Conclusions: glucose pretransplante and cyclosporin A were associated with the greatest risk for developing new-onset diabetes after transplantation. The behavior observed in these patients with transplant should be confirmed with later studies.